Other inpatient surgical procedures — exploratory laparotomy and damage-control surgery
Customize your policy alerts
Sign up for all mediviewcurative policy alerts
Know when mediviewcurative releases new policies or updates existing guidance.
Monitor payer policy activity
Defines inpatient utilization-management criteria for exploratory laparotomy (trauma/acute abdomen) and damage-control (abbreviated) laparotomy, including admission, discharge, continued-stay, coding crosswalks, and level-of-care guidance for Curative Health Plan.
Inpatient Coverage Criteria
inv-01: Exploratory laparotomy — Admission — Covered when ALL of the following apply:
Covered when ALL of the following apply:
From Section A.
inv-02: Damage-control surgery — Admission — Covered when ALL of the following apply:
Covered when ALL of the following apply:
From Section A; lethal triad thresholds cited.
inv-03: Retroperitoneal sarcoma: Admission/medical necessity criteria — admission covered when ALL severity criteria and at least ONE intensity-of-service criterion are met
Admission for retroperitoneal sarcoma is covered when ALL of the following severity criteria are met and at least ONE intensity-of-service criterion is present.
All severity items required.
At least one intensity criterion required.
inv-04: Pheochromocytoma resection: Admission/medical necessity criteria — covered when ALL severity criteria and at least ONE intensity-of-service criterion are met
Admission for pheochromocytoma resection is covered when ALL severity criteria are met and at least ONE intensity-of-service criterion is present.
All severity items required; pre-op optimization cited.
At least one intensity criterion required.
inv-05: Extended stay criteria — Continued inpatient stay beyond goal LOS covered when ONE OR MORE documented medical-necessity triggers are present
Continued inpatient stay beyond goal LOS is covered when ONE OR MORE of the following documented medical-necessity triggers are present and accompanied by clinical evidence and a targeted intervention plan.
Document specific trigger, supporting clinical evidence, and targeted intervention plan.
inv-06: COVERAGE CRITERIA — general covered when ALL of the following are met for inpatient admission and stay documentation
Covered when ALL of the following are met for inpatient admission and stay documentation:
See DRG/CPT crosswalk and ICU considerations.
Examples: neck hematoma requiring evacuation; persistent hypocalcemia requiring IV calcium; recurrent laryngeal nerve injury with airway concerns; pheochromocytoma post-op hemodynamic instability beyond 48 h.
inv-07: Inpatient parathyroidectomy for hypercalcemic crisis — Covered when ALL of the following are met
Covered when ALL of the following are met:
Routine parathyroidectomy is outpatient; inpatient only for hypercalcemic crisis or other inpatient needs.
inv-08: Standalone oncologic lymph node dissection — Covered when ALL of the following are met
Covered when ALL of the following are met:
Therapeutic lymphadenectomy for biopsy-confirmed node-positive disease; sentinel node biopsy alone is outpatient unless other factors justify inpatient care.
inv-09: Continued stay and Extended Stay Criteria — daily surgical team review required and when Goal LOS is exceeded ONE OR MORE triggers required
Continued inpatient stay requires daily surgical team review and documentation of clinical reasons; when Goal LOS is exceeded, ONE OR MORE of the following triggers must be documented with supporting evidence and an intervention plan.
From Continued Stay / Concurrent Review section.
Documentation must state specific trigger, supporting clinical evidence, and targeted intervention plan.
Admissions for procedures that can be performed safely in an ambulatory surgery center with same‑day discharge are not appropriate for inpatient status. Examples include diagnostic procedures alone that do not require overnight recovery. Also included are pre‑operative admissions >1 day before surgery for non‑medical reasons (admit day of surgery unless medical optimization is required), continued post‑operative stays when all discharge criteria are met, continued stays solely awaiting facility placement when the member is medically ready, and post‑operative stays that extend beyond the expected length of stay without documented medical justification.
Damage‑control surgery does not meet inpatient criteria when the procedure or related care could be completed in an ambulatory surgery center with same‑day discharge or when the admission is solely for a diagnostic procedure that does not require overnight recovery. Pre‑operative admission more than one day before the scheduled surgery for non‑medical reasons should be avoided (admit the day of surgery unless medical optimization is necessary). Continued post‑operative stays that meet all discharge criteria, stays solely awaiting placement once medically ready, and extensions of post‑operative stay beyond expected LOS without medical justification are considered not medically necessary.
Retroperitoneal sarcoma resections that can be performed safely in an ambulatory surgery center with same‑day discharge or that are diagnostic procedures only (not requiring overnight recovery) do not meet inpatient admission criteria. Pre‑operative admission >1 day before surgery for non‑medical reasons is not appropriate. Continued post‑operative stays when all discharge criteria are met, stays solely for placement when medically ready, and post‑operative stays beyond the expected length of stay without documented medical necessity are considered not medically necessary.
When sentinel node biopsy alone is performed, it is identified as an outpatient procedure and is not an inpatient indication for a full lymph node dissection. A completion or full dissection may warrant inpatient care only when clinical or anatomic factors justify inpatient recovery and monitoring; otherwise sentinel node biopsy alone should be managed as outpatient.
Admissions or continued inpatient stays that meet any of the listed 'does not meet criteria' items are not medically necessary. These include procedures safely performed in an ambulatory surgery center with same‑day discharge, diagnostic‑only admissions that do not require overnight recovery, pre‑operative admissions >1 day before surgery for non‑medical reasons, continued post‑operative stays when all discharge criteria are met, continued stays solely awaiting facility placement when the patient is medically ready, and post‑operative stays extending beyond the expected length of stay without documented medical justification.
Continued post‑operative inpatient stay is not appropriate when the patient has met all discharge criteria. Extending the stay beyond the expected length of stay without documentation of a medical‑necessity trigger (for example an anastomotic leak requiring intervention, postoperative ileus >5 days requiring NG decompression and TPN, surgical site infection, or postoperative hemorrhage requiring transfusion or re‑operation) places the admission at risk for denial. Documentation should support the specific clinical reason and planned intervention.
Routine inpatient admission for primary hyperparathyroidism is not medically necessary and should be denied in the absence of hypercalcemic crisis. Inpatient parathyroidectomy is covered only when the patient meets severity criteria such as hypercalcemic crisis (serum calcium >14 mg/dL) with altered mental status, cardiac arrhythmia, dehydration requiring IV resuscitation, or when concurrent comorbidities or mediastinal exploration necessitate inpatient monitoring.
Procedure and Diagnosis Codes
| DRG 329-331 | Major Bowel Procedures (if bowel surgery performed) |
| DRG 393-395 | Other Digestive System OR (if no bowel procedure) |
| CPT 49000-49010 | Exploratory laparotomy CPT range |
| DRG 003-004 | Tracheostomy with MV (if prolonged) |
| DRG 329-331 | Major Bowel (if bowel) |
| DRG 957 | Other OR for Multiple Trauma |
| DRG 329-331 | Major Bowel Procedures (if bowel surgery performed) |
| DRG 393-395 | Other Digestive System OR (if no bowel procedure) |
| DRG 003-004 | Tracheostomy with MV (if prolonged) |
| DRG 957 | Other OR for Multiple Trauma |
| C48.0 | Malignant neoplasm of retroperitoneum |
| C49.4 | Malignant neoplasm of connective tissue of abdomen - soft tissue sarcoma |
| D48.3 | Neoplasm of uncertain behavior of retroperitoneum |
| CPT 49203-49215 | Excision retroperitoneal tumor by size (plus organ resection codes as needed) |
| E27.5 | Adrenomedullary hyperfunction (pheochromocytoma) |
| D35.00 | Benign neoplasm of unspecified adrenal gland |
| D35.01 | Benign neoplasm of right adrenal gland |
| D35.02 | Benign neoplasm of left adrenal gland |
| C74.10 | Malignant neoplasm of medulla of adrenal gland |
| CPT 60540 | Adrenalectomy, open |
| CPT 60545 | Adrenalectomy with excision of adjacent retroperitoneal tumor |
| CPT 60650 | Laparoscopic adrenalectomy |
| DRG 628-630 | Other Endocrine/Nutritional Procedures |
| CPT 60540-60650 | Adrenalectomy codes; intraoperative hemodynamic lability common |
| DRG 820-822 | Other OR Procedures |
| DRG 329-331 | If bowel resected |
| CPT 49203-49215 | Retroperitoneal tumor excision; LOS 5-10 days |
| 60540-60650 | CPT range for pheochromocytoma resection (document lists range) |
| C77.0 | Secondary malignant neoplasm of lymph nodes of head, face and neck |
| C77.1 | Secondary malignant neoplasm of intrathoracic lymph nodes |
| C77.2 | Secondary malignant neoplasm of intra-abdominal lymph nodes |
| C77.3 | Secondary malignant neoplasm of axilla and upper limb lymph nodes |
| C77.4 | Secondary malignant neoplasm of inguinal and lower limb lymph nodes |
| C77.5 | Secondary malignant neoplasm of intrapelvic lymph nodes |
| 38740 | Axillary lymphadenectomy, complete |
| 38745 | Axillary lymphadenectomy, radical including pectoral muscles |
| 38760 | Inguinal lymphadenectomy, superficial |
| 38765 | Inguinal lymphadenectomy, superficial and deep |
| DRG 628-630 | Other Endocrine/Nutritional Procedures |
| DRG 625-627 | Thyroid/Parathyroid Procedures |
| 38740-38780 | CPT range for lymph node dissection procedures |
| DRG 582-583 | Breast |
| DRG 740-742 | GYN |
| DRG 656-658 | GU |
| DRG 129-130 | Head & Neck |
Authorization, Documentation, and Billing Guidance
Prior authorization / utilization management
Inpatient surgical procedures in this section are governed by Curative's utilization-management criteria; automated systems may approve but must not issue adverse determinations, and all denials require licensed clinician review.
Include diagnosis and CPT groups on authorization
Include the listed diagnosis and CPT groups on surgical admission and authorization requests for retroperitoneal sarcoma and related resections: ICD-10-CM C48.0, C49.4, D48.3 and CPT 49203-49215 (plus organ resection codes as needed). For pheochromocytoma, include ICD-10-CM E27.5, D35.00-D35.02, C74.10 and CPT 60540-60650.
- Retroperitoneal sarcoma: C48.0, C49.4, D48.3; CPT 49203-49215
- Pheochromocytoma: E27.5, D35.00-D35.02, C74.10; CPT 60540-60650
Use provided coding crosswalks for procedures
Use the policy's coding crosswalks when submitting authorizations and claims; crosswalks map procedure CPT ranges to MS-DRG groups for pheochromocytoma, parathyroidectomy, and lymph node dissection to support level-of-care and billing decisions.
- Pheochromocytoma: CPT 60540-60650 → DRG 628-630
- Parathyroidectomy: CPT 60500-60505 → DRG 625-627
- Lymph node dissection: CPT 38740-38780 → DRG varies by primary site (e.g., 582-583, 740-742)
Authorizations: CPT 38740–38780 for lymph node dissection
When requesting authorization or coding inpatient admissions for lymph node dissection, include CPT codes in the 38740–38780 range; determine inpatient versus outpatient status based on extent/location (sentinel node biopsy alone is outpatient).
- CPT 38740-38780 should be listed on authorization/billing when applicable
- Sentinel node biopsy alone is outpatient and should not be authorized as inpatient unless clinical/anatomic factors justify admission
Pre-op optimization: document alpha‑blockade ≥14 days and optimization
Document preoperative medical optimization for pheochromocytoma: adequate alpha‑blockade for ≥14 days (e.g., phenoxybenzamine or doxazosin), followed by beta‑blockade and volume expansion, and that anesthesia is experienced in pheochromocytoma management.
- Record duration/type of alpha‑blockade (≥14 days)
- Document subsequent beta‑blockade and volume expansion
- Confirm anesthesia team experienced in pheochromocytoma care
Document diagnosis, CPT(s), and justification for inpatient care
Document diagnosis codes, operative CPT(s), and the clinical justification for inpatient-level care (severity of illness and intensity of service) on the admission and authorization.
When Goal LOS is exceeded, document specified medical‑necessity triggers
If the patient's stay exceeds the policy Goal LOS, document ONE OR MORE specified medical‑necessity triggers (e.g., anastomotic leak requiring intervention, postoperative ileus >5 days requiring NG decompression and TPN, surgical site infection, pancreatic fistula ISGPF grade B/C, bile leak requiring drainage/ERCP, or post‑op hemorrhage requiring transfusion/reoperation) with clinical evidence and a targeted intervention plan.
- Specify which trigger is present and provide supporting clinical data
- Describe the targeted intervention plan tied to the trigger
Admission documentation: support both severity and intensity
Admission for complex procedures must include documentation of both severity of illness (e.g., biopsy‑confirmed retroperitoneal sarcoma or biochemically confirmed pheochromocytoma with imaging) and intensity of service (surgical procedure requiring inpatient recovery or postoperative monitoring).
- Attach biopsy/imaging reports confirming diagnosis and resectability
- State the expected inpatient postoperative services or monitoring needs
Extended‑stay documentation must identify trigger, evidence, and plan
When Goal LOS is exceeded, documentation must state ONE OR MORE medical‑necessity triggers, identify the specific trigger, provide clinical evidence supporting it, and include a targeted intervention plan (examples include post‑op hemodynamic instability beyond 48 h for pheochromocytoma).
- Name the trigger and link to objective findings (labs, imaging, drains, transfusions)
- Provide a time‑bound intervention plan and responsible team
Admission documentation must support severity and intensity (examples)
Admission documentation must demonstrate severity of illness and intensity of service for the planned procedure (for example, biopsy‑confirmed node‑positive disease for therapeutic lymph node dissection or Ca >14 mg/dL with associated features for inpatient parathyroidectomy).
- Include biopsy/pathology or lab thresholds (e.g., Ca >14 mg/dL) as applicable
- Describe why postoperative inpatient recovery/monitoring is needed
Extended stay: identify trigger(s), supporting evidence, and plan
When Goal LOS is exceeded, the record must identify ONE OR MORE medical‑necessity triggers, provide clinical evidence supporting the trigger, and document a targeted intervention plan to address it.
- State the specific trigger(s) present
- Attach supporting evidence (imaging, labs, consultant notes) and intervention timeline
Licensed clinician review required for denials
All denials require review and sign‑off by a licensed clinician; automated systems may be used to approve but must not issue adverse determinations without clinician review.
Denial risk: continued stay without medical justification or awaiting placement
Continued post‑operative inpatient stay without documented medical justification, or continued stay solely to await facility placement when medically ready, is a denial trigger and may be considered not medically necessary.
- Activate case management for discharge planning rather than inpatient extension
- Document clinical reasons if discharge is delayed for medical necessity
Denial for routine parathyroidectomy without hypercalcemic crisis
Inpatient admission for routine primary hyperparathyroidism without hypercalcemic crisis (Ca ≤14 mg/dL without associated crisis features) is denied; inpatient parathyroidectomy is limited to hypercalcemic crisis or concurrent medical need.
- Hypercalcemic crisis defined as Ca >14 mg/dL with AMS, arrhythmia, or dehydration requiring IV resuscitation and medical therapy
Denial risk: extended post‑op stay without documented medical need
Continued post‑operative stay beyond the expected/Goal LOS without documented medical justification, or solely to await placement, will be denied.
- Ensure documentation of one or more accepted medical‑necessity triggers if stay exceeds Goal LOS
Documentation + concurrent review required to avoid denial for extended stays
Failure to document daily surgical team review and the medical‑necessity trigger(s) when Goal LOS is exceeded — including supporting evidence and a targeted intervention plan — may lead to denial under CMS 2‑midnight and inpatient payment rules.
- Document daily surgical team notes and rationale for continued inpatient care
- When extended stay is claimed, include trigger, evidence, and intervention plan
Clinical Background
Exploratory laparotomy is indicated for the acute abdomen and related surgical emergencies. Typical admission indications include acute abdomen with peritonitis requiring emergent surgical exploration, penetrating abdominal trauma with hemodynamic instability or peritonitis, blunt abdominal trauma with a positive FAST exam and hemodynamic instability, radiographic pneumoperitoneum, or evisceration. Damage‑control (abbreviated) laparotomy is used for massively injured or physiologically deranged trauma patients to rapidly control hemorrhage and contamination with temporary abdominal closure and a planned return to the operating room.
Key Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.